Effects of treatment of peripheral pain generators in fibromyalgia patients
The DOI matches its Crossref record; 6 of the 6 references it cites were found in a registry or an index.
Abstract
Fibromyalgia syndrome (FS) frequently co-occurs with regional pain disorders. This study evaluated how these disorders contribute to FS, by assessing effects of local active vs placebo treatment of muscle/joint pain sources on FS symptoms. Female patients with (1) FS+myofascial pain syndromes from trigger points (n=68), or (2) FS+joint pain (n=56) underwent evaluation of myofascial/joint symptoms [number/intensity of pain episodes, pressure pain thresholds at trigger/joint site, paracetamol consumption] and FS symptoms [pain intensity, pressure pain thresholds at tender points, pressure and electrical pain thresholds in skin, subcutis and muscle in a non-painful site]. Patients of both protocols were randomly assigned to two groups [34 each for (1); 28 each for (2)] to receive active or placebo local TrP or joint treatment [injection/hydroelectrophoresis] on days 1 and 4. Evaluations were repeated on days 4 and 8. After therapy, in active--but not placebo-treated-- groups: number and intensity of myofascial/joint episodes and paracetamol consumption decreased and pressure thresholds at trigger/joint increased (p<0.001); FS pain intensity decreased and all thresholds increased progressively in tender points and the non-painful site (p<0.0001). At day 8, all placebo-treated patients requested active local therapy (days 8 and 11) vs only three patients under active treatment. At a 3-week follow-up, FS pain was still lower than basis in patients not undergoing further therapy and had decreased in those undergoing active therapy from day 8 (p<0.0001). Localized muscle/joint pains impact significantly on FS, probably through increased central sensitization by the peripheral input; their systematic identification and treatment are recommended in fibromyalgia.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
The american college of rheumatology 1990 criteria for the classification of fibromyalgia
Wolfe, F., Smythe, H. A., Yunus, M. B., Bennett, R. M., Bombardier, C., Goldenberg, D. L., Tugwell, P., Campbell, S. M., Abeles, M., Clark, P., et al. (1990) · Arthritis & Rheumatism · doi:10.1002/art.1780330203 · Cited by 9,563
Wolfe, F., Clauw, D. J., Fitzcharles, M., Goldenberg, D. L., Katz, R. S., Mease, P., Russell, A. S., Russell, I. J., Winfield, J. B., & Yunus, M. B. (2010) · Arthritis Care & Research · doi:10.1002/acr.20140 · Cited by 3,952 · cited 2×
“…as fibromyalgic according to ACR (1990) – as in the present study – would thus remain with this diagnosis with the new criteria (Cöster et al., 2008; Wolfe et al., 2010), suggesting that FS can be diagnosed for clinical purposes by both symptom-based and ACR criteria (strong consensus according…”
BackgroundEULAR evidence-based recommendations for the management of fibromyalgia syndrome
Carville, S. F., Arendt-Nielsen, S., Bliddal, H., Blotman, F., Branco, J. C., Buskila, D., Da Silva, J. A. P., Danneskiold-Samsøe, B., Dincer, F., Henriksson, C., et al. (2008) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2007.071522 · Cited by 752
Clauw, D. J. (2009) · The American Journal of Medicine · doi:10.1016/j.amjmed.2009.09.006 · Cited by 350 · cited 1×
“A typical feature of FS is a generalized increase in pain sensitivity, revealed by decreased pain thresholds to different stimulus modalities at somatic level in both painful and non-painful areas (Vecchiet et al., 1994; Carli et al., 2002; Giamberardino, 2008; Clauw, 2009).”
BackgroundUnderstanding fibromyalgia: lessons from the broader pain research community.
Williams, D. A., & Clauw, D. J. (2009) · The Journal of Pain · doi:10.1016/j.jpain.2009.06.001 · Cited by 250 · cited 1×
“…to pain in FS would also seem related to abnormalities in descending efferent pathways, i.e., dysfunction/impairment of the many neural systems that contribute to the descending inhibitory pathways (Abeles et al., 2007; Schweinhardt et al., 2008; Williams and Claw, 2009; Sommer, 2010).”
BackgroundCöster, L., Kendall, S., Gerdle, B., Henriksson, C., Henriksson, K. G., & Bengtsson, A. (2008) · European Journal of Pain · doi:10.1016/j.ejpain.2007.10.001 · Cited by 119 · cited 1×
“…so far identified as fibromyalgic according to ACR (1990) – as in the present study – would thus remain with this diagnosis with the new criteria (Cöster et al., 2008; Wolfe et al., 2010), suggesting that FS can be diagnosed for clinical purposes by both symptom-based and ACR criteria…”
Background
Cited by
Fibromyalgia: A Clinical Review
Clauw, D. J. (2014) · JAMA · doi:10.1001/jama.2014.3266 · Cited by 1,674
Fibromyalgia: an update on clinical characteristics, aetiopathogenesis and treatment
Sarzi-Puttini, P., Giorgi, V., Marotto, D., & Atzeni, F. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-00506-w · Cited by 793
AAPT Diagnostic Criteria for Fibromyalgia
Arnold, L. M., Bennett, R. M., Crofford, L. J., Dean, L. E., Clauw, D. J., Goldenberg, D. L., Fitzcharles, M.-A., Paiva, E. S., Staud, R., Sarzi-Puttini, P., et al. (2019) · The Journal of Pain · doi:10.1016/j.jpain.2018.10.008 · Cited by 420
Nijs, J., Paul van Wilgen, C., Van Oosterwijck, J., van Ittersum, M., & Meeus, M. (2011) · Manual Therapy · doi:10.1016/j.math.2011.04.005 · Cited by 390
Lee, Y. C., Nassikas, N. J., & Clauw, D. J. (2011) · Arthritis Research & Therapy · doi:10.1186/ar3306 · Cited by 377
Dry needling — peripheral and central considerations
Dommerholt, J. (2011) · Journal of Manual & Manipulative Therapy · doi:10.1179/106698111x13129729552065 · Cited by 315
Clauw, D. J., Arnold, L. M., & McCarberg, B. H. (2011) · Mayo Clinic Proceedings · doi:10.4065/mcp.2011.0206 · Cited by 303
Hyperexcitable C nociceptors in fibromyalgia
Serra, J., Collado, A., Solà, R., Antonelli, F., Torres, X., Salgueiro, M., Quiles, C., & Bostock, H. (2014) · Annals of Neurology · doi:10.1002/ana.24065 · Cited by 295
“For example, it has been shown that lidocaine injection of tender points or local treatment of peripheral muscle/joint pain sources not only increases local pain thresholds, which could be explained by the block of the peripheral afferent barrage, but also decreases widespread pain and remote hyperalgesia.(26,27) The…”
BackgroundMyofascial pain syndromes and their evaluation
Bennett, R. (2007) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2007.02.014 · Cited by 278
Fibromyalgia: A Critical and Comprehensive Review
Borchers, A. T., & Gershwin, M. E. (2015) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-015-8509-4 · Cited by 275
Fibromyalgia and related conditions
Clauw, D. J. (2015) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2015.03.014 · Cited by 259
“Thus, a recent study reported that individuals with FM with comorbid osteoarthritis or myofascial pain had improvement in their overall FM pain and tenderness when these were treated with local therapies.(63,64) There is also emerging evidence that some individuals with FM exhibit a small fiber neuropathy on biopsy,(6…”
BackgroundTreatment of central sensitization in patients with ‘unexplained’chronic pain: An update
Nijs, J., Malfliet, A., Ickmans, K., Baert, I., & Meeus, M. (2014) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.2014.925446 · Cited by 195
“studied the effect of trigger point or joint injection/ hydroelectrophoresis as a way to treat peripheral pain generators in patients with fibromyalgia [52].”
BackgroundReview: Central pain mechanisms in the rheumatic diseases: Future directions
Phillips, K., & Clauw, D. J. (2013) · Arthritis & Rheumatism · doi:10.1002/art.37739 · Cited by 195
“perpetuation of central augmentation interventions (76).”
Diagnosing and treating chronic musculoskeletal pain based on the underlying mechanism(s)
Clauw, D. J. (2015) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2015.04.024 · Cited by 169
Rombaut, L., Scheper, M., De Wandele, I., De Vries, J., Meeus, M., Malfait, F., Engelbert, R., & Calders, P. (2015) · Clinical Rheumatology · doi:10.1007/s10067-014-2499-0 · Cited by 91
“Once central sensitization is established, any new peripheral injury may serve as a new source of input, which sustains or aggravates the process of central sensitization [43].”
BackgroundNeutrophils infiltrate sensory ganglia and mediate chronic widespread pain in fibromyalgia
Caxaria, S., Bharde, S., Fuller, A. M., Evans, R., Thomas, B., Celik, P., Dell’Accio, F., Yona, S., Gilroy, D., Voisin, M.-B., et al. (2023) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2211631120 · Cited by 89
Visceral pain as a triggering factor for fibromyalgia symptoms in comorbid patients
Costantini, R., Affaitati, G., Wesselmann, U., Czakanski, P., & Giamberardino, M. A. (2017) · Pain · doi:10.1097/j.pain.0000000000000992 · Cited by 76
“symptoms, and their local treatments also improve FMS pain and tenderness.(3,23) Similarly, the co-occurrence of an additional pain condition such as migraine increases FMS pain.”
InfluentialSelf-citationCastro Sánchez, A. M., García López, H., Fernández Sánchez, M., Pérez Mármol, J. M., Aguilar-Ferrándiz, M. E., Luque Suárez, A., & Matarán Peñarrocha, G. A. (2019) · Disability and Rehabilitation · doi:10.1080/09638288.2018.1461259 · Cited by 64
Ablin, J. N., Lang, E., Catalogna, M., Aloush, V., Hadanny, A., Doenyas-Barak, K., Finci, S., Polak, N., Fishlev, G., Korin, C., et al. (2023) · PLOS ONE · doi:10.1371/journal.pone.0282406 · Cited by 30
Metadata
- Authors
- Affaitati, G., Costantini, R., Fabrizio, A., Lapenna, D., Tafuri, E., & Giamberardino, M. A.
- Venue
- European Journal of Pain
- Publisher
- Wiley
- Published
- 2011-01
- Volume
- 15
- Issue
- 1
- Pages
- 61-69
- ISSN
- 1090-3801 (ISSN-L)
- OpenAlex
- W1981628733
- Cited by
- 153
- References
- 6
- FWCI
- 8.57
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.